Jul 17, 2018
Learn About Love: Salimetrics Launches Salivary Oxytocin Testing Service
Jun 14, 2018
Global Nitric Oxide Therapy Systems (Portable & Fixed) Market 2017-2026 - Market is Expected to Expand at a CAGR of 5.19%
May 29, 2018
Scientists show how brain circuit generates anxiety
Apr 12, 2018
Global & Chinese L-Adrenaline Brtartrate (CAS 51-42-3) Industry Report 2018 - ResearchAndMarkets.com
Apr 09, 2018
Vanda to Present Tradipitant Scientific Posters at the 10th Georg Rajka International Symposium of Atopic Dermatitis
Jan 03, 2018
Indivior and Addex Enter Strategic Collaboration to Accelerate Development of GABA(B) PAMs for Addiction Disorder Treatments
Dec 21, 2017
Global Aspartic Acid Market - High Demand from the Food and Beverage Industry to Boost Growth | Technavio
Nov 30, 2017
Smartphone Addiction Creates Imbalance in Brain
Nov 07, 2017
Global Nitric Oxide Therapeutics Report 2017: Markets and Companies Analysis 2016-2017 & Projectiosn to 2026
Oct 30, 2017
Biohaven Announces First Patient Treated In Clinical Research Collaboration At Rutgers Cancer Institute
Oct 24, 2017
Aldeyra Therapeutics Presents Evidence for Aldehyde Sequestration as a Potential Therapeutic Approach in Succinic Semialdehyde Dehydrogenase Deficiency at the American Society of Human Genetics 2017 Annual Meeting
Oct 06, 2017
Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing
Oct 05, 2017
Aldeyra Therapeutics Announces Presentation of Novel Data on the Efficacy of ADX-102 in a Model of Succinic Semialdehyde Dehydrogenase Activity at the 2017 American Society of Human Genetics Annual Meeting
Oct 02, 2017
Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of Itch
Sep 21, 2017
Aptinyx to Present at Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
Sep 05, 2017
Ajinomoto Newsletter: MSG Equals Umami?!
Aug 25, 2017
Production and Market of Glycine in China - 2017-2021 - Research and Markets
Aug 01, 2017
Mallinckrodt Enrolls First Patient In Phase 4 Registry Of INOMAX® (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates
Jun 05, 2017
Novoteris, LLC Receives FDA and Health Canada Clearance to Start a Phase 2 Clinical Trial of Its Thiolanox® Nitric Oxide for the Treatment of Cystic Fibrosis